Smith Nephew Profile

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 35px;;'>SNN</div>

Performance

15 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for Smith Nephew SNATS are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 29, 2019 and ending today January 27, 2020. Click here to learn more.

Smith Nephew Profile

Smith Nephew plc develops, manufactures, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 16000 people. more on Smith Nephew
Legal NameSmith Nephew SNATS
CEONamal NawanaView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Smith Nephew SNATS
Piotroski F Score
Academic score to determine the current strength of Smith Nephew SNATS financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Smith Nephew SNATS ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Smith Nephew representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Smith Nephew SNATS (SNN) is traded on BATS Exchange in USA and employs 16,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 22.13 B. Smith Nephew SNATS runs under Healthcare sector within Medical Devices industry. The entity has 437.54 M outstanding shares of which 1.9 M shares are at this time shorted by investors with about 2.72 days to cover shorted positions. SMITH&NEPHEW PLC has about 137 M in cash with 1.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check Smith Nephew Probability Of Bankruptcy

Ownership Allocation (%)

Smith Nephew Target Price Odds Analysis

Odds Below 50.57HorizonTargetOdds Above 50.57
97.49%30 days 50.57 2.48%
Based on normal probability distribution, the odds of Smith Nephew to move above current price in 30 days from now is roughly 2.48 (This Smith Nephew SNATS probability density function shows the probability of Smith Nephew Stock to fall within a particular range of prices over 30 days) .

Smith Nephew SNATS Top Holders

Smith Nephew SNATS Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Smith Nephew Against Markets

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Smith Nephew Corporate Filings

Smith Nephew SEC Reporting

Unclassified Corporate Event

Smith Nephew Corporate Directors

Michael Friedman Non-Executive Independent Director
Erik Engstrom Non-Executive Independent Director
Marc Owen Non-Executive Independent Director
Additionally take a look at World Market Map. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.
Company logos by clearbit